There was no significant difference in OS between the different melanoma subtypes in the retrospective cohort ( p = 0.727), but mucosal melanoma showed a trend towards poorer OS (Supplementary Material 5).
← all excerpts
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study.
1
—
—